2 This article reviews the science behind GLP-1 for tobacco use disorder, including semaglutide, tirzepatide, exenatide, and the investigational drug retatrutide, plus ongoing clinical trials and what to know about smoking or vaping while taking these medications
Updated Review of Clinicaltrials.gov Authors Alorfi NM , Alshehri FS Received 16 May 2023 Accepted for publication 7 July 2023 Published 31 July 2023 Volume 2023:16 Pages 21792187 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Scott Fraser Nasser M Alorfi, Fahad S Alshehri Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia Correspondence: Nasser M Alorfi, Pharmacology and Toxicology Department, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia, Tel +966 500644261, Email [email protected] Background: Obesity in both adults and children is a primary health concern that can lead to many complications at a young age, including insulin resistance, type 2 diabetes, and other diseases
This process leads to an even skin tone, a lighter complexion, and an all-over healthy glow
For many women, especially those with metabolic dysfunction, it increases fertility
